Connective tissue-type mast cells degranulate in response to a neurogenic peptide, substance P, whereas bone marrow-derived mast cells (BMMC) do not respond to this stimulant when prepared with a combination of interleukin-3 and interleukin-4. In the present study we demonstrated that BMMC obtained from three different strains of mice, NC, BALB/c and C57BL/6, which are immature mast cells low in histamine content and unresponsive to substance P, increased 10 to 100-fold in their histamine content and acquired responsiveness to substance P after coculture with NIH/3T3 fibroblasts in the presence of 10 ng/mL of stem cell factor (SCF). This change was observed after 1 week of co-culture and increased over a 3 week period, whereas 3T3 fibroblasts or SCF (100 ng/mL) alone was insufficient to duplicate this phenotypic change in BMMC. It is suggested that the response to substance P of mast cells is not through NK-1 receptors but rather through a different mechanism, since the reverse transcriptase-mediated polymerase chain reaction technique failed to show expression of NK-1 receptor mRNA in BMMC after coculture as well as before co-culture.
INTRODUCTION
Mast cells originate from hematopoietic cells located in bone marrow. Precursors of mast cells circulate in the blood, reach tissues, and then differentiate depending on the micro-environment of the tissue. Mouse mast cells that reside in serosal cavities and skin, connective tissuetype mast cells (CTMC), differ in a number of ways with respect to phenotype from mouse mast cells that reside in mucosa of the intestine, mucosal mast cells (MMC). The CTMC are stained with safranin and berberine sulfate, have heparin in their granules, and have a relatively high histamine content (approximately 10 pg/cell), whereas the MMC do not react to these dyes, have predominantly chondroitin sulfates in their granules, and have a low histamine content (approximately 1 pg/cell).1,2 In addition, CTMC degranulate in response to neurogenic peptides such as substance P, vasoactive intestinal peptide, and somatostatin, from 10-6 to 10-4 mol/L, whereas MMC respond weakly or hardly at all to these peptides.: ' By culturing bone marrow cells in vitro with interleukin (IL)-3 and IL-4, mast cells can be easily obtained in a pure preparation (BMMC). These cells cause degranulation by stimulation with IgE and antigen. They are thus thought to be useful for investigating the biochemical events involved in degranulation. These cells resemble MMC but are still immature. They also differ from CTMC histochemically and functionally. One remarkable difference in function between BMMC and CTMC is responsiveness to neurogenic peptides. Bone marrow-derived mast cells fail to react to neurogenic peptides, such as substance P, whereas CTMC release significant amounts of histamine in response to 10-5 rnol/L substance p'3 The mechanism of this functional differentiation in mast cells is unclear.
Several studies demonstrated that when the BMMC are co-cultured with mouse skin-derived 3T3 fibroblasts, the BMMC acquire biochemical characteristics resembling CTMC; that is, the mast cells acquire the ability to be stained with safranin, to increase histamine content, and to synthesize hepcrin.v'' Fibroblasts thus playa key role in the differentiation of mast cell precursors into CTMC. Also of interest is the fact that a potent mast cell growth factor, stem cell factor (SCF), has been identified in fibroblasts, and is encoded in the SI locus and ligand for the c-kit proto-oncogene product." Numerous studies both in vitro and in vivo have shown the importance of SCF in the development of mast cells."
In this study we demonstrated that mouse BMMC acquire responsiveness to substance P by co-culture with NIH/3T3 fibroblasts in the presence of soluble SCF, and that this response of co-cultured mast cells is not due to expression of a specific substance Preceptor, NK-1.
MATERIALS AND METHODS

Animals
Six-week-old BALB/c and C57BL/6 male mice were purchased from Nihon SLC (Hamamatsu, Japan). NC mice were provided by Dr J Hayakawa, Institute for Experimental Animals, School of Medicine, Kanazawa University, Japan.
Growth factors and chemicals
Mouse recombinant IL-3, mouse recombinant IL-4, and mouse recombinant SCF were purchased from R&D Systems Inc. (Minneapolis, MN, USA). Substance P and human serum albumin (HSA)-conjugated dinitrophenol (DNP) were purchased from Sigma Chemical Co. (St Louis, MO, USA). Rat anti-DNP-lgE was purchased from BioSource International (Camarillo, CA, USA).
Cell culture
NIH/3T3 fibroblast cell line was obtained from Dainippon Pharmaceutical Co. Ltd (Osaka, Japan) and cultured in a-minimal essential medium (aMEM) (Dainippon) supplemented with 5% calf-serum, 2 mmol/L glutamine, 100 IU/mL penicillin G and 100 /-lg/mL streptomycin. Bone marrow-derived mast cells were obtained by culturing bone marrow cells from 6-weekold male mice as previously described." Briefly, bone marrow cells were suspended at a density of 1 X 10 6 cells/mL in aMEM supplemented with 10% fetal calfserum (FCS), 50/-lmol/L 2-mercaptoethanol, 2 mrnol/L glutamine, 100 IU/mL penicillin G, 100 /-lg/mL streptomycin, 5 ng/mL IL-3, and 2 ng/mL IL-4. The cell suspension was then transferred into a 25 ern? culture flask and cultured for over 4 weeks by replacing half of the medium with fresh medium each week. After 4 weeks, more than 98% of nonadherent cells were stained positively with alcian blue.
Co-culture of BMMC and 313 fibroblasts
In this study 3T3 fibroblasts were suspended in 0.5 mL of aMEM supplemented with 10% FCS, 2 rnrnol/L glutamine, 100 IU/mL penicillin G, 100 uq/rnl, streptomycin (complete aMEM) at a density of 6 X 
Aldan blue/safranin staining of cultured cells
Cells suspended in 70 ul. of aMEM with 1% bovine serum albumin were cytocentrifuged on glass slides, air dried, and fixed in Carnoy's solution (30% chloroform, 10% acetic acid in ethanol) for 20 min. The cells fixed on glass slides were incubated with 0.5% alcian blue in 0.3% acetic acid for 60 min, washed with water, and further incubated with 0.1 % safranin in 1% acetic acid for 5 min. After being washed again with water, the cells were embedded in a mounting reagent. Connective tissue-type mast cells from the peritonea of normal mice were used as positive controls for safranin staining.
Histamine release assay
Suspensions of BMMC were equilibrated at 3JOC for 5 min, and then incubated in 1.5 mL polypropylene test tubes containing serially diluted substance P in complete aMEM supplemented with 5 ng/mL IL-3 and 2 ng/mL IL-4 for 20 min. Substance P was dissolved in saline containing 0.04% acetic acid at a concentration of were denaturation at 94°C for 1 min, annealing at 55°C for 2 min, and extension at 72°C for 3 min over 35 cycles in a DNA thermal cycler (Astec PC700, Fukuoka, Japan). The PCR products (10 ul) were electrophoresed in 1.5% agar gels in 1 X TAE buffer (40 rnrnol/l. Tris, 20 mmol/L acetic acid, 2 mmol/L Na3 EDTA) at a constant 100 V for 2 h. Products were visualized by ethidium bromide over a UV transilluminator (CSF-20B, CosmoBio, Tokyo, Japan) and photographed. Predicted sizes of PCR products were 681 bp for c-kit and 666 bp for NK-1 receptor.
Statistical analysis
Data were analyzed using the Mann-Whitney U-test. Results were expressed as either the mean ± SD or mean ± SEM.
Probability (P) values less than 0.05 were considered to be significant.
RESULTS
Co-culture of BMMC with 3T3 fibroblasts
By culturing bone marrow cells with a combination of 5 ng/mL IL-3 and 2 ng/mL IL-4 for 4 weeks, a virtually pure mast cell preparation (BMMC) was available in three different strains: NC, BALB/c, and C57BL/6. Histamine content of these BMMC varied as indicated in Table 1 .
When 3 X 10 4 BMMC were co-cultured with mouse 3T3 fibroblasts in complete aMEM, only approximately 50% of the initially seeded BMMC were still present after 1 week, 30% after 2 weeks, and 10% after 3 weeks. In contrast to this progressive loss of mast cells, when cocultured with mouse 3T3 fibroblasts in the presence of SCF the growth of BMMC was enhanced in a dosedependent manner, and the growth reached a plateau above 10 ng/mL of SCF (data not shown). With 10 ng/mL of SCF, the number of mast cells more than doubled in the first week, but thereafter decreased gradually. After 3 weeks of co-culture in the presence of 10 ng/mL SCF, the with the initial value, the amount of histamine per cell increased significantly during co-culture in the presence of 10 ng/mL SCF (Table 1) . After 3 weeks, the histamine content of co-cultured mast cells was enhanced considerably more than that of BMMC kept in suspension culture with IL-3 and IL-4. Bone marrow-derived mast cells were not stained by safranin at all, whereas 10-30% of the mast cells became safranin-positive when co-cultured with 3T3 fibroblasts in the presence of 10 ng/mL SCF (Table 1) . 
Substance P-induced histamine release from mast cells
Bone marrow-derived mast cells did not secrete histamine when exposed to substance P in a range from 10-7 to 10-5 rnol/L among the three different strains of mice (NC, BALB/c and C57BL/6), although these cells released up to 50% of total histamine when stimulated by 10-1000 ng/mL HSA-ONP after being sensitized by anti-ONP IgE antibody. When BMMC were maintained with 100 ng/mL SCF in suspension culture for 3 weeks, no remarkable response was observed to 10-7 to 10-5 rnol/L of substance P (data not shown). Bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of additional growth factors decreased in number; 3 weeks later only approximately 10% of the mast cells survived. These mast cells still contained low amounts of histamine, but did not respond to substance P. However, they began to respond to substance P 1 week after being placed in co-culture with 3T3 fibroblasts in the presence of 10 ng/mL SCF (Fig. 1) . By 3 weeks, co-cultured mast cells released approximately 20% of total histamine when exposed to 10-5 rnol/L substance P (Fig. 1) . Histamine was released in a dose-dependent manner in a range from 10-7 to 10-5 rnol/L (Fig. 20) . In contrast, BMMC grown by themselves did not show any response to substance P in concentrations up to 10-5 mol/l.. This unresponsiveness of mast cells was constant during the suspension culture with 5 ng/mL IL-3 and 2 ng/mL IL-4 for up to 6 months (data not shown). When activated with HSA-ONP after sensitization with 0.5 Ilg/mL IgE, both BMMC and co-cultured mast cells released significant amounts of histamine in similar dose-dependent manners (Fig. 2b) . Although percentage histamine release was found to be similar in BMMC and co-cultured mast cells, Predicted sizes of peR products were 68 1 bp for c-kit and 666 bp for NK-l receptor. 
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NK-1 receptor mRNA expression
Since the NK-1 receptor recognizes substance P, we examined NK-1 receptor mRNA expression in BMMC and co-cultured mast cells by the RT-PCR technique. Analysis of PCR amplification with specific primers for the NK-1 receptor gene failed to show mRNA expression for the NK-1 receptor in either BMMC or co-cultured mast cells in the presence of 10 ng/mL SCF (Fig. 4) .
DISCUSSION
Substance P is a member of the tachykinin family and resides in primary sensory cutaneous neurones, both in dorsal root ganglia and in distal nerve terminals. Anti- C-terminal residues of substance P are considered to penetrate the membrane to activate membrane-coupled G-proteins in a receptor-independent manner, resulting in histamine release. However, the effective dose of substance P to activate G-proteins (10-5 to 10-3 rnol/I) is much higher than that required for mast cell octivoticn.i" The fact that neuraminidase treatment induces the desensitization of mast cells to substance P suggests that negative charges of sialic acid residues facilitate the action of substance P. Another substance P receptor with low affinity, although not yet identified, might be involved in the activation of CTMC. Mast cell activation by substance P is not likely to be mediated through the NK-2 receptor, which shows 10 to 1OO-fold lower affinity for substance P than neurokinin A, because neurokinin A, a high affinityagonist to the NK-2 receptor, does not stimulate mast cell degranulation. Nor have we detected NK-2 receptor mRNA in cocultured mast cells or BMMC by RT-PCR (data not shown). A difference in Co ' ' concentration in the reaction solution was also unlikely to have affected the responsiveness of co-cultured BMMC, because the Ca 2 + concentration in the reaction was kept constant in the medium, somewhat below physiological condition throughout the experiments. In this study we have achieved a functional differentiation of BMMC into cells strongly resembling CTMC by co-culture with NIH/3T3 fibroblasts in the presence of lower concentration of SCF, presumably resembling the micro-environment of dermis in skin. Our results imply that this functional phenotypic change of mast cells is seen in general for mice, because BMMC obtained from three different strains of mice (NC, BALB/c and C57BL/6) acquired responsiveness to substance P after co-culture with 3T3 fibroblasts in the presence of SCF. Our results also imply that the response to substance P of co-cultured BMMC is not through the NK-l receptor.
